Safety study of Aramchol meglumine tablet in healthy people
This trial tests how the body processes a new form of Aramchol (meglumine tablet) after single and repeated doses. It is for healthy volunteers to check safety and drug levels in the blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man or woman
- Your body mass index (BMI) is between 18 and 30.9 (a measure of weight relative to height)
- You agree to use contraception as required by the study
- You do not smoke or have not smoked in the last 3 months
- You do not have any serious medical condition or infection like hepatitis B, C, or HIV
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This trial tests a new medicine called HL-003 in healthy people to see if it is safe and how the body processes it. You may join if you are generally healthy, between 18 and 50 years old, and meet specific health and lifestyle requirements.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
This trial tests how the body processes ammoxetine in people with mild or moderate liver impairment compared to people with normal liver function. It aims to find out if the drug is safe and how it works in these groups.
This is an early-stage safety study testing a new tablet called BGM0504 in healthy volunteers. Researchers want to understand how the body handles this drug and check for any side effects.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.